Jun 6, 2019   SOURCE: PR NewsWire

Varian Showcasing Latest Proton Therapy Systems and Technology at PTCOG Conference 58

PALO ALTO, Calif., June 6, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its new ProBeam(®) 360° proton therapy system*, June 12(th)-15(th) in Manchester, United Kingdom at the 58(th) PTCOG Conference (Particle Therapy Co-Operative Group). Designed for next-generation proton therapy, the ProBeam 360° system offers uncompromised clinical capabilities, a 360-degree gantry, and RapidScan((TM)) technology, which simplifies the process of motion management by delivering each field in a single breath-hold.

At PTCOG58, Varian will be demonstrating its fully integrated proton solution:

    --  Eclipse((TM)) PT Treatment PlanningEclipse elevates plan quality and
        fidelity in the presence of uncertainty with robust optimization and
        Monte Carlo dose calculation

    --  RapidPlan((TM)) PT Knowledge-based PlanningRapidPlan leverages machine
        learning to make high-quality plans in a fraction of the time while
        providing knowledge-guided decision support

    --  Velocity((TM) )Velocity, incorporated with Eclipse PT, aggregates
        treatment and imaging data to show comprehensive view of a patient's
        diagnostic imaging and treatment history, allowing clinicians to track
        and adapt changes during the course of treatment.

    --  360 Oncology((TM) )Care Management The 360 Oncology care management
        platform helps inform, empower and engage patients and the entire
        oncology care team. It offers collaborative tools to engage patients in
        their care, more effectively manage tumor boards, make informed
        treatment recommendations, and create survivorship care plans

    --  Noona(®)An intuitive patient-reported outcomes (PRO) solution, Noona
        automates patient monitoring, symptom management and patient triage

Varian will also be holding several events at PTCOG 58:

    --  FlashForward((TM)) Consortium Meeting (invite only): The FlashForward
        Consortium is focused on preclinical research, clinical implementation
        and advocacy efforts for FLASH Therapy. The meeting will take place on
        Tuesday June 11th, 12:00pm-5:00pm at Manchester Central.
    --  Varian Proton Solutions Users Meeting: Topics to be discussed include
        flash therapy research on the ProBeam system and decision support
        modeling with RapidPlan(TM) PT on Wednesday June 12th, 8:30am-1:30pm at
        Radisson Blu Edwardian.
    --  Varian Lunch Symposium: Ricky Sharma, MA, FRCP, FRCR, PhD, Dee Khuntia,
        MD, chief medical officer at Varian, and Renate Parry, PhD, Sr.
        director, global translational science at Varian will discuss the
        potential of FLASH Therapy, Thursday June 13th, 12:15pm-1:30pm at the
        Manchester Central - Exchange Auditorium.
    --  The Christie Tour & Reception: Varian will be sponsoring a tour of the
        facility which houses the ProBeam system, on Friday June 14th,
        6:00pm-9:00pm for the conference attendees.

*CE Mark and international registration pending. Not available for sale in all markets.

About Varian
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact

Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com

Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com

View original content:http://www.prnewswire.com/news-releases/varian-showcasing-latest-proton-therapy-systems-and-technology-at-ptcog-conference-58-300862954.html

SOURCE Varian